211 related articles for article (PubMed ID: 27922807)
21. Towards a Saphenous Vein Graft Moratorium.
Motwani A; Ayinapudi K; Singh T; Maini R; Hendel R; Le Jemtel TH
Cardiol Rev; 2020; 28(5):236-239. PubMed ID: 31985520
[TBL] [Abstract][Full Text] [Related]
22. Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.
Ota H; Mahmoudi M; Lhermusier T; Magalhaes MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015 Dec; 16(8):441-6. PubMed ID: 26704310
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
Harskamp RE; Kuijt WJ; Damman P; Beijk MA; Grundeken MJ; Woudstra P; Tijssen JG; de Winter RJ
Catheter Cardiovasc Interv; 2014 Feb; 83(2):203-9. PubMed ID: 22508617
[TBL] [Abstract][Full Text] [Related]
24. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
Brilakis ES; Wang TY; Rao SV; Banerjee S; Goldman S; Shunk K; Kar B; Holmes DR; Dai D; Chin CT; Harding TM; Roe MT
JACC Cardiovasc Interv; 2010 Oct; 3(10):1068-73. PubMed ID: 20965466
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
[TBL] [Abstract][Full Text] [Related]
26. Saphenous vein grafts: two substrates, two treatments?
Hillegass WB; Brott BC
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1137. PubMed ID: 23225651
[No Abstract] [Full Text] [Related]
27. Percutaneous Coronary Intervention of Saphenous Vein Graft.
Redfors B; Généreux P; Witzenbichler B; McAndrew T; Diamond J; Huang X; Maehara A; Weisz G; Mehran R; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495896
[TBL] [Abstract][Full Text] [Related]
28. Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study.
Pasceri V; Tarsia G; Niccoli G; Viceconte N; Porto I; Leone AM; Trani C; Speciale G; Lisanti P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1112-7. PubMed ID: 22422701
[TBL] [Abstract][Full Text] [Related]
29. Association between paraoxonase activity and late saphenous vein graft occlusion in patients with coronary artery bypass grafting.
Cagirci G; Cay S; Karakurt O; Yazihan N; Aydin C; Acikel S; Dogan M; Kilic H; Topaloglu S; Aras D; Akdemir R
Kardiol Pol; 2009 Oct; 67(10):1063-8. PubMed ID: 20017071
[TBL] [Abstract][Full Text] [Related]
30. Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009).
Brennan JM; Sketch MH; Dai D; Trilesskaya M; Al-Hejily W; Rao SV; Brilakis E; Messenger JC; Shaw RE; Anstrom KJ; Peterson ED; Douglas PS
Catheter Cardiovasc Interv; 2016 Jan; 87(1):43-9. PubMed ID: 26153480
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
Bansal D; Sachdeva R; Mehta JL
J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
[No Abstract] [Full Text] [Related]
32. Stents and failing vein grafts: are we any wiser after ISAR?
Taggart DP; Banning AP
Lancet; 2011 Sep; 378(9796):1054-5. PubMed ID: 21872921
[No Abstract] [Full Text] [Related]
33. Stent implantation in saphenous vein grafts.
Lozano I; Avanzas P; Rondan J
Am J Cardiol; 2009 Apr; 103(7):1042-3. PubMed ID: 19327440
[No Abstract] [Full Text] [Related]
34. Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.
Chakravarty T; Morrissey RP; Wertman B; Naghi J; Chou S; Goykhman P; Doctor N; Mirocha J; Forrester JS; Makkar R
Catheter Cardiovasc Interv; 2012 May; 79(6):903-9. PubMed ID: 21805570
[TBL] [Abstract][Full Text] [Related]
35. The use of drug-eluting stents in venous coronary artery bypass grafts.
Hernandez-Antolín R; Alfonso F; Jimenez P
EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
[TBL] [Abstract][Full Text] [Related]
36. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions.
Rozenman Y
JACC Cardiovasc Interv; 2011 May; 4(5):590-1; author reply 591-3. PubMed ID: 21596337
[No Abstract] [Full Text] [Related]
37. Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.
Hoffmann R; Nitendo G; Deserno V; Adamu U; Almalla M; Blindt R; Vogt F
Coron Artery Dis; 2010 Mar; 21(2):61-4. PubMed ID: 20124993
[TBL] [Abstract][Full Text] [Related]
38. The quest for optimal interventional strategy in saphenous vein graft interventions--are we there yet?
Gupta S; Cigarroa JE
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1118-9. PubMed ID: 23225650
[No Abstract] [Full Text] [Related]
39. Long drug-eluting stent implantation for a diffusely diseased right internal mammary artery.
Niccoli G; Biscione C; Conte M; Crea F
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):381-3. PubMed ID: 17443108
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients.
Hakeem A; Helmy T; Munsif S; Bhatti S; Mazraeshahi R; Cilingiroglu M; Effat M; Leesar M; Arif I
Catheter Cardiovasc Interv; 2011 Feb; 77(3):343-55. PubMed ID: 21328679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
